期刊文献+

LY294002对多药耐药急性白血病细胞株HL60/VCR的凋亡及细胞周期的影响研究 被引量:2

Effect of LY294002 on Cell Cycle and Apoptosis of Multidrug Resistant HL60/VCR Cell Line
原文传递
导出
摘要 目的:研究磷脂酰肌醇-3-激酶(PI3K)抑制剂LY294002对多药耐药急性白血病细胞株HL60/VCR凋亡与细胞周期的影响及可能机制。方法:取耐长春新碱(VCR)的HL60/VCR多药耐药急性白血病细胞株分为未加药的对照组及加入不同浓度的LY294002(其终浓度为1.0、2.5、5.0、10μmol.L-1)组,MTT法检测2种细胞的半数抑制浓度(IC50),流式细胞仪检测细胞凋亡及细胞周期分布,半定量逆转录-聚合酶链反应(RT-PCR)检测抗凋亡蛋白Bcl-2、细胞周期调控分子CyclinD1mRNA表达。结果:与对照组比较,LY294002可明显降低HL60/VCR对VCR的IC50(P<0.05),且与剂量相关;LY294002可显著增加HL60/VCR细胞凋亡率,阻滞细胞于G0/G1期,降低HL60/VCR细胞的Bcl-2、CyclinD1mRNA的表达(P均<0.05)。结论:LY294002可能是通过影响Bcl-2及CyclinD1基因的表达,从而促进HL60/VCR细胞凋亡及抑制细胞增殖。 OBJECTIVE: To explore the effect of the specific inhibitor - LY294002 of the signaling pathway PI3K/AKT on cell cycle and apoptosis of HL60/VCR cells and its mechanism. METHODS: Vincristine (VCR) resistant HL60/VCR were treated with LY294002 (final concentration at 1.0, 2.5, 5.0, or 10 μmol·L^-1) or without LY294002 (control) . IC50 was detected by MTT; flow cytometry was used to evaluate apoptosis and cell cycle distribution, and changes of Bcl- 2, CyclinD1 gene mRNA levels were detected by reverse transcription polymerase chain reaction. RESULTS: As compared with control, LY294002 significantly reduced the IC50 value in HL60/VCR to vincristine in a concentration dependent manner (P 〈 0.05) . LY294002 significantly increased the rate of apoptosis, arrested cells in G0/G1 phase and reduced the levels of Bcl - 2 and CyclinD1 mRNA (all P 〈 0.05). CONCLUSION: The underlying mechanism for LY 294002 to promote apoptosis of HL60/VCR and suppress cell Droliferation lies in its imoact on Bcl - 2 level and CycllinD1 gene expression .
作者 黄必义
出处 《中国药房》 CAS CSCD 北大核心 2008年第22期1709-1711,共3页 China Pharmacy
关键词 LY294002 多药耐药 急性白血病细胞株HL60/VCR 细胞凋亡 细胞周期 LY 294002 Multidrug resistant HL60/VCR Apoptosis Cell cycle
  • 相关文献

参考文献9

  • 1李国青,茆俊卿,张育.中药逆转肿瘤多药耐药非经典机制的研究进展[J].中国药房,2007,18(6):465-467. 被引量:5
  • 2刘民锋,余险峰,郭伟,董泾青,左石,罗剑,徐立宁,邹声泉.PI3K/AKT特异性抑制剂LY294002对胆管癌细胞化疗增敏作用的研究[J].山东医药,2006,46(8):6-7. 被引量:4
  • 3Barancik M, Bohacova V, Sedlak J, et al. LY294002, a specific inhibitor of PI3K/Akt kinase pathway,antago- nizes P- glycoprotein mediated multidrug resistance [J ]. Eur J Pharm Sci, 2006, 29(5):426.
  • 4Kubota Y, Ohnishi H, Kitanaka A, et al.Constitutive activation of PI3K is involved in the spontaneous proliferation of primary acute myeloid leukemia cells: direct evidence of PI3K activation [J ] . Leukemia , 2004, 18(8) :1 438.
  • 5Beurel E, Kornp robst M, Blivet Van Eggelpoel MJ, et al. GSK 3beta inhibition by lithium confers resistance to chemotherapy- induced apoptosis through the repression of CD95 (Fas/APO 1) expression[J] . Exp Cell Res ,2004,300(2) :354.
  • 6朴瑛,陈协群,刘丽梅,洪流,刘景华,周凡,刘彦琴.bcl-2小干扰RNA对HL-60/VCR细胞耐药性逆转的研究[J].中国实验血液学杂志,2005,13(6):1010-1013. 被引量:5
  • 7Ramos AM, Fernandez C, Amran D, et al. Pharmacologic inhibitors of PI3K/ Akt potentiate the apoptotic action of the antileukemic drug arsenic trioxide via glutathione depletion and increased peroxide accumulation in myeloid leukemia cells [J ]. Blood, 2005,105(10) : 4 013.
  • 8Cory AH, Somerville L, Cory JG. Blockage of cyclin cdk's,PKC and phosphoinositol 3- kinase pathways leads to augmentation of apoptosis in drug -resistant leukemia cells: evidence for interactive effects of flavopiridol, LY294002, roscovitine, wortmannin and MCN 01[J ] .Anticancer Res, 2005,25(1A) : 101.
  • 9Mirshahi P, Toprak SK, Faussat AM, et al. Malignant hematopoietic cells induce an increased expression of VEGFR- 1 and VEGFR 3 on bone marrow endothelial cells via AKT and mTOR signalling pathways[J ] . Biochem Bioph ys Res Commun , 2006,349(3):1 003.

二级参考文献26

共引文献11

同被引文献10

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部